천장관절 고정 수술 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 유형별, 적응증별, 접근법별, 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Sacroiliac Joint Fusion Surgery Market Growth & Trends:

The global sacroiliac joint fusion surgery market size is expected to reach USD 984.9 million by 2030, registering a CAGR of 19.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing product launches and approvals are driving market growth. In March 2023, CoreLink Surgical received 510(k) clearance from the U.S. FDA for its Siber Ti Sacroiliac Joint Fusion System, which encompasses a diverse range of fully porous, nano-surfaced, 3D-printed implants in its portfolio. Similarly, in March 2022, Life Spine, Inc. received FDA clearance for marketing its SImpact SI Joint Fixation System for posterior-oblique approaches.

Sacroiliitis is often used interchangeably with SI joint dysfunction, specifically the pain arising from the SI joint. The increasing number of SI cases is a pivotal factor contributing to the increasing adoption of diverse treatment options, propelling the market growth. According to Wolters Kluwer Health, Inc. data, as of April 2020, approximately 33.3% of the global population is afflicted by SI joint dysfunction. Furthermore, this source highlights that lumbar pain is prevalent in 50% to 80% of cases, contributing to SI joint dysfunction. Clinical assessments reveal that approximately 15% to 30% of individuals experiencing lumbar pain also concurrently suffer from SI joint dysfunction. Consequently, the increasing prevalence of sacroiliitis or SI joint dysfunction is poised to be a significant factor driving SI joint fusion surgery market growth.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing product formation and reach. In addition, the players are securing funding from government and non-government bodies to develop advanced treatment. For instance, in September 2023, PainTEQ introduced its latest surgery-ready instrument set, which represents a significant progression in the field of SI joint fusion surgery. This set of surgical instruments for PainTEQ's LinQ procedure comprises surgery-ready, single-use instruments, providing interventional pain physicians with a safer and more economical alternative.

The growing adoption of surgeries for the treatment of sacroiliac joint pain is fostering market growth. Furthermore, the increasing availability of reimbursement coverage for healthcare expenses bolsters the affordability and accessibility of these treatments. Increasing funding and government support are further accelerating market growth. The increasing prevalence of lower back, buttock, groin, and lower extremity pain is driving the market growth.

Sacroiliac Joint Fusion Surgery Market Report Highlights:

• Based on indication, the degenerative sacroiliitis segment held the largest revenue share in the market in 2023 owing to the increasing prevalence of degenerative sacroiliitis.
• Based on type, the minimally invasive surgery (MIS) segment is anticipated to grow at the fastest CAGR over the forecast period in the market owing to a rising preference for MIS.
• Based on approach, the dorsal & anterior segment is anticipated to grow at the fastest CAGR over the forecast period. This is due to the advantages associated with this approach, which include direct curettage and bone grafting into the sacroiliac joint area, resulting in good bone union.
• Based on product, the implants segment is anticipated to grow at the fastest CAGR over the forecast period in the market owing to rising advancements in technology & materials.
• Based on end use, the hospitals segment held the largest revenue share in the market in 2023 owing to the increasing preference of patients and the increased number of surgeries conducted within hospital settings.
• North America dominated the market due to the presence of key industry leaders in the region. In addition, the region's advanced healthcare infrastructure, coupled with the increasing availability of reimbursement coverage, is driving market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Indication outlook
  • 2.2.3. Approach outlook
  • 2.2.4. Product outlook
  • 2.2.5. End use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Sacroiliac Joint Fusion Surgery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Sacroiliac Joint Fusion Surgery: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Framework

Chapter 4. Sacroiliac Joint Fusion Surgery Market Segment Analysis, By Indication, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Indication Market Share Analysis, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Sacroiliac Joint Fusion Surgery Market, by Indication, 2018 to 2030
• 4.5. Degenerative sacroiliitis
  • 4.5.1. Degenerative sacroiliitis market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Sacral disruption
  • 4.6.1. Sacral disruption market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Trauma
  • 4.7.1. Trauma market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Sacroiliac Joint Fusion Surgery Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Type Market Share Analysis, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Sacroiliac Joint Fusion Surgery Market, by Type, 2018 to 2030
• 5.5. MIS
  • 5.5.1. MIS market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Open
  • 5.6.1. Open market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Sacroiliac Joint Fusion Surgery Market Segment Analysis, By Approach, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Approach Market Share Analysis, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Sacroiliac Joint Fusion Surgery Market, by Approach, 2018 to 2030
• 6.5. Dorsal & Anterior
  • 6.5.1. Dorsal & anterior market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Lateral
  • 6.6.1. Lateral market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Sacroiliac Joint Fusion Surgery Market Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 7.1. Definition and Scope
• 7.2. Product Market Share Analysis, 2023 & 2030
• 7.3. Segment Dashboard
• 7.4. Global Sacroiliac Joint Fusion Surgery Market, by Product, 2018 to 2030
• 7.5. Implants
  • 7.5.1. Implants market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Accessories
  • 7.6.1. Accessories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Sacroiliac Joint Fusion Surgery Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 8.1. Definition and Scope
• 8.2. End use Market Share Analysis, 2023 & 2030
• 8.3. Segment Dashboard
• 8.4. Global Sacroiliac Joint Fusion Surgery Market, by End use, 2018 to 2030
• 8.5. Hospitals
  • 8.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.6. Ambulatory surgical centers
  • 8.6.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.7. Others
  • 8.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Sacroiliac Joint Fusion Surgery Market Segment Analysis, By Region, By Type, By Indication, By Approach, By Product, By End Use, 2018 - 2030 (USD Million)

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Regional Market Snapshot
• 9.4. Sacroiliac Joint Fusion Surgery Market Share by Region, 2023 & 2030:
• 9.5. North America
  • 9.5.1. North America sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. U.S. sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Canada sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Mexico sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. UK sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Germany sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. France sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Italy sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Spain sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.7. Norway
    • 9.6.7.1. Norway sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.8. Sweden
    • 9.6.8.1. Sweden sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.6.9. Denmark
    • 9.6.9.1. Denmark sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Japan sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. China sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. India sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Australia sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. South Korea sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Thailand sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Brazil sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Argentina sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. South Africa sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Saudi Arabia sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. UAE sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Kuwait sacroiliac joint fusion surgery market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Profiles
  • 10.3.1. SI-BONE, Inc.
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Product benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. CornerLoc
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Product benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. Globus Medical
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. Orthofix Medical, Inc.
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Camber Spine Technologies, LLC
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Life Spine, Inc.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. CoreLink Surgical
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. PainTEQ
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. SIGNUS Medizintechnik GmbH
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Medtronic
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives